Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual therapy group offers new hope for rare genital disorder

NCT ID NCT05919784

Symptom relief Sponsor: Dr. Caroline Pukall Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an 8-week online group therapy program for women with Persistent Genital Arousal Disorder (PGAD), a condition causing unwanted, intense genital sensations. Eight women from Ontario took part in virtual sessions that taught coping skills and provided support. The goal was to see if the program could ease symptom intensity and distress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

Apr 2023

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * at least 18 years of age * fluent in English * have a physician-based diagnosis of PGAD/GPD * reside in Ontario, Canada * be comfortable answering questions about their health (mental and physical) and sexuality in online surveys * be comfortable discussing their mental and physical health and PGAD/GPD symptoms in group online therapy sessions with video on Exclusion Criteria: * under the age of 18 years * nonfluent in English * lack of physician based diagnosis of PGAD/GPD * not comfortable with answering questions about mental, physical, sexual health * not comfortable with discussing mental and physical health and PGAD/GPD symptoms in group online therapy sessions with video on * mental or physical health conditions that preclude involvement in group therapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Persistent genital arousal disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Persistent genital arousal disorder

Contacts and locations

Locations

  • Sexual Health Research Laboratory, Department of Psychology, Queen's University

    Kingston, Ontario, K7L 3N6, Canada